Dr. Gramza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-444-2223
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2004 - 2007
- University of New Mexico School of MedicineResidency, Internal Medicine, 2000 - 2003
- Ohio State University College of MedicineClass of 2000
Certifications & Licensure
- OR State Medical License 2004 - Present
- DC State Medical License 2015 - 2024
- VA State Medical License 2012 - 2016
- NM State Medical License 2003 - 2004
Clinical Trials
Publications & Presentations
PubMed
- 102 citationsRandomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.Julie Ann Sosa, Rossella Elisei, Barbara Jarzab, Jai Balkissoon, Shiao Ping Lu
Thyroid. 2014-02-11 - 13 citationsA Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.Jaydira Del Rivero, Renee N. Donahue, Jennifer L. Marte, Ann W. Gramza, Marijo Bilusic
Frontiers in Endocrinology. 2020-08-07 - 6 citationsA phase II study of tarloxotinib (a hypoxia activated prodrug of a pan-erb tyrosine kinase inhibitor) in patients with recurrent or metastatic squamous cell carcinoma ...Luke S McLean, Tessa A Morris, Ann Gramza, Stephen Liu, Saad A Khan
Investigational New Drugs. 2022-08-01
Press Mentions
- Impact of Drug, Genomic Innovations on Thyroid Cancer TreatmentJune 30th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: